Secure your tomorrow's tea today
Preserve your youngest cells today, so tomorrow’s medicine can work with the best version of you: your cells, healthy and ready.
MyCells
Imagine arriving 20 or 30 years from now and still being able to rely on the cells you had when you were in perfect health. MyCells was created to make this scenario realistic, turning an abstract thought about the “future” into a concrete choice you make today to bring yourself closer to it.
Young cells, not those of tomorrow
By preserving your cells now, you freeze their biological clock and protect them from infections, pollutants, radiation, and replication errors that affect DNA throughout life.
Total compatibility with you
The cells are yours, genetically identical to you: when they are used, the risk of rejection will be zero.
A bridge to new therapies
Preserved cells may be reprogrammed into iPSCs, from which it is possible to obtain neurons, cardiac cells, pancreatic cells, and many other cell types that are currently at the center of clinical studies and, increasingly, regulated clinical pathways.
How the MyCells Pathway Works
The pathway is designed so that you can make an important choice without disrupting your daily life.
Talk to our team and check your eligibility: find out if MyCells is right for you and your health conditions.
A venous blood draw performed directly at home or at an affiliated facility, in a single scheduled session.
At the Eternacell/SSCB laboratories, mononuclear cells (PBMCs) are isolated, selected, and cryopreserved at approximately −180 °C, preserving their biological properties at the time of collection.
Your cells can be reprogrammed into iPSCs and, when science and clinical guidelines allow, they can be differentiated into the cell types needed to support new therapeutic approaches.
Who is it intended for
- Individuals up to 65 years old who are currently healthy and wish to safeguard their cells as an investment in their biological future.
- For those who want to invest in their biological future
- For those who want to ensure access to future treatments without rejection as they are developed
What will you be able to do tomorrow?
EternaCell monitors the evolution of induced pluripotent stem cells (iPSCs)
Numerous clinical studies are currently active worldwide, exploring applications in cardiology, neurology, endocrinology (type 1 diabetes), orthopedics, and oncology/immunotherapy, with ongoing activities.
And today there is an additional signal: in Japan, the Ministry of Health has approved the commercialization of the world’s first two therapies derived from iPSCs (for ischemic cardiomyopathy and Parkinson’s disease). It is a historic milestone that makes the pathway tangible: from clinical studies to the first regulated applications — and makes the arrival of new indications in the coming years plausible.
Our goal is to make these technologies accessible to clients as soon as they become available, in full respect of scientific evidence and regulatory pathways
Take the first step
Fill out the form and speak with one of our experts. We will help you determine if MyCells is suitable for your situation and guide you in discovering the potential of our service.